Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.APP Pharmaceuticals has launched Granisetron hydrochloride injection, 0.1 mg/mL, one mL single dose vials, the generic equivalent of Hoffmann-LaRoche's Kytril injection.
Subscribe to our email newsletter
APP’s Granisetron is AP-rated, preservative and latex-free, and bar-coded. Granisetron hydrochloride injection is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose cisplatin and radiation cancer therapy. Granisetron hydrochloride injection is also indicated for the prevention of postoperative nausea.